During the past decade, Throne Biotechnologies conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Throne Biotechnologies" #1 collaborator was "Hackensack Meridian Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Throne Biotechnologies" are "Alopecia Areata" (1 trials), "Alopecia Totalis" (1 trials), "Alopecia Universalis" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "Throne Biotechnologies" in a lesser frequency.

Most popular intervention types in "Throne Biotechnologies" are "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Stem Cell Educator therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Throne Biotechnologies" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Throne Biotechnologies". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Throne Biotechnologies, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Throne Biotechnologies, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".